PURE RED CELL APLASIA INDUCED BY ERYTHROPOIETIN

Introduction: Recombined human erythropoietin has been present in clinical practice for more than 20 years, in these therapeutic indications: anemia in kidney insufficiency, anemia during chemotherapy of tumors, prevention of anemias that appear in premature born babies, it is used for increasing au...

Full description

Bibliographic Details
Published in:	Sanamed
Main Authors:	MIhajlovic Filip, Milosavljevic Aleksandar, Djuric Dusan
Format:	Article
Language:	English
Published:	Association of medical doctors Sanamed Novi Pazar 2018-05-01
Subjects:	erythropoietin side effects anti-erythropoietin antibodies pure red cell aplasia.
Online Access:	http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/197/106

Similar Items

Pure red cell aplasia secondary to erythropoietin therapy
by: Gwenno Mair Edwards, et al.
Published: (2024-07-01)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
by: Maryam Rahbar, et al.
Published: (2017-01-01)

Research progress on antibody-mediated pure red cell aplasia in chronic kidney disease
by: You Xiaoe, Ma Hualin, Wang Zhen, Zhang Xinzhou, Guo Baochun
Published: (2023-06-01)

The Use of Darbepoetin to Stimulate Erythropoiesis in the Treatment of Anemia of Chronic Kidney Disease in Dogs
by: E.H. Fiocchi, et al.
Published: (2017-03-01)

Clinico-Hematological Features in Pure Red Cell Aplasia Patients Diagnosed at Diagnostic & Research Laboratory, Hyderabad
by: Faheem Ahmed Memon
Published: (2020-12-01)

Pure red cell aplasia and associated thymoma
by: Cristian Rosu, et al.
Published: (2011-04-01)

Invasive thymoma with pure red cell aplasia and amegakaryocytic thrombocytopenia
by: Takuya Onuki, et al.
Published: (2016-12-01)

Pure Red Cell Aplasia That Developed 13 Years After Thymoma Treatment: A Case Report and Literature Review
by: Kento Kono, et al.
Published: (2025-09-01)

Baseline Soluble Anti-erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients With End-Stage Renal Disease: A Prospective Cohort Study
by: Ying Zhang, et al.
Published: (2020-04-01)

Anesthetic management of a pregnant patient with a pure red cell aplasia
by: Channabasavaraj S Sanikop, et al.
Published: (2013-01-01)

Idiopathic pure red cell aplasia: A case series from India
by: Manoj U Mahajan, et al.
Published: (2023-05-01)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
by: Carolina Castillo Hernández, et al.
Published: (2017-01-01)

Effective treatment of refractory monoclonal gammopathy‐associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone
by: Christian Sebastian Michel, et al.
Published: (2024-08-01)

Association between anti-erythropoietin antibody levels and treatment response in hemodialysis patients with end-stage renal disease: A cross-sectional study from Iraq
by: Samer Imad Mohammed, et al.
Published: (2026-01-01)

Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia
by: Destini Teague, et al.
Published: (2022-12-01)

Tacrolimus-Induced Pure Red Cell Aplasia Following Renal Transplantation: A Case Report and Literature Review
by: Dilek Barutçu Ataş, et al.
Published: (2021-02-01)

A Case of Systemic Lupus Erythematosus Presenting as Pure Red Cell Aplasia
by: Maria Saeed, et al.
Published: (2021-04-01)

APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01)

Emtricitabine-induced pure red cell aplasia
by: Nithendra Manickchund, et al.
Published: (2019-09-01)

Pure red cell aplasia in chronic lymphocytic leukemia: Case report and review of literature
by: Hassanain H Al-Charrakh, et al.
Published: (2016-01-01)

Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01)

Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
by: Nagwa S. Ahmed, et al.
Published: (2023-02-01)

THE PURE RED BLOOD CELL APLASIA IN RENAL TRANSPLANT RECIPIENT
by: B. T. Dzumabaeva, et al.
Published: (2011-06-01)

Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study
by: Yasuhiro Mochida, et al.
Published: (2022-08-01)

Aberrant Hematopoiesis and CD8+ T‐Cell Activation in Thymoma‐Associated Pure Red Cell Aplasia
by: Mengyuan Liu, et al.
Published: (2025-03-01)

One case report and literature review about pure red cell aplasia following renal transplantation
by: CAI Yan, et al.
Published: (2015-01-01)

Low-Dose Linperlisib Achieves Rapid Hematological Response in a Patient with Pure Red Cell Aplasia and Moderate-to-Severe Renal Insufficiency: A Case Report
by: Chuanhuan Liu, et al.
Published: (2026-06-01)

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
by: Thiti Asawapanumas, et al.
Published: (2022-01-01)

CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS
by: V. D. Nazarov, et al.
Published: (2018-01-01)

Antierythropoietin Antibodies in Hemodialysis Patients Treated with Recombinant Erythropoietin
by: Savaş ÖZTÜRK, et al.
Published: (2019-02-01)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
by: Sun Yong Lee, et al.
Published: (2020-05-01)

Pure Red Cell Aplasia Induced by Atezolizumab in a Patient with Small-Cell Lung Cancer Successfully Treated with Steroid Therapy: A Case Report
by: Keita Kawakado, et al.
Published: (2023-12-01)

The Adverse Reactions of Erythropoietin in Methanol Toxicity: A Descriptive Study
by: Vahidreza Mohebpour, et al.
Published: (2024-02-01)

Treatment of pure red cell aplasia in a chronic kidney disease patient with roxadustat: A case report
by: Liu Shanlin, et al.
Published: (2025-10-01)

Unusual Presentation of B-Cell Chronic Lymphocytic Leukemia Accompanied by Pure Red Cell Aplasia: Case Report
by: Jane Atallah, et al.
Published: (2024-01-01)

Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor
by: Shuo Miao, et al.
Published: (2017-12-01)

Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia
by: Mehmet Sezgin Pepeler, et al.
Published: (2024-12-01)

A whistleblower direct antiglobulin test in chronic kidney disease: An interesting case of occult autoimmune hemolytic anemia in an undiagnosed lymphoma with pure red cell aplasia
by: Rasika Dhawan Setia, et al.
Published: (2026-01-01)

Erythropoietin Has Kidney Protective Efficacy beyond Stimulating Erythropoiesis
by: Mahmoud Rafieian-Kopaei, et al.
Published: (2013-07-01)

Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
by: A. M. Kudryashova, et al.
Published: (2020-01-01)